Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Go back to Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca| Pfizer Inc. (NYSE: PFE) | Delayed: 27.66 +0.02 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.64 | 52 Week High | $37.39 | |||
| Open | $27.64 | 52 Week Low | $28.25 | |||
| Day High | $27.66 | P/E | 16.76 | |||
| Day Low | $27.34 | EPS | $1.65 | |||
| Volume | 75,587,710 | |||||
| Sumitomo Chemical Co Ltd Unsponsored ADR (AMEX: SOMMY) | Delayed: 18.50 -0.25 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.75 | 52 Week High | $30.01 | |||
| Open | $18.50 | 52 Week Low | $19.54 | |||
| Day High | $18.50 | P/E | N/A | |||
| Day Low | $18.50 | EPS | $0.00 | |||
| Volume | 369 | |||||
